Nader Francois
SEC CIK 1365343 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| MRNA | Moderna | Dir | 32.8K | — | $435.0K | 4 | 2022-04-28 | 2026-04-30 |
Most active insiders at MRNA, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Bancel Stephane | CEO, Dir | — | $28.72M |
| 2 | Hoge Stephen | Pres | — | $28.43M |
| 3 | Mock James M | CFO | — | $4.69M |
| 4 | Klinger Shannon Thyme | CLO | — | $1.39M |
| 5 | AFEYAN NOUBAR | Dir | — | $1.14M |
| 6 | Hussain Abbas | Dir | — | $278.9K |
| 7 | Horning Sandra | Dir | — | — |
| 8 | NABEL ELIZABETH G | Dir | — | — |
| 9 | Rubenstein David M. | Dir | — | — |
| 10 | Nader Francois | Dir | — | — |
Transactions 4
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-05-04 16:48 | 2026-04-30 | MRNA | Moderna | Nader Francois | Dir | M - OptEx | — | +12.2K | 32.8K | +59% | — |
| D | 2022-05-12 | 2022-05-10 | MRNA | Moderna | Nader Francois | Dir | M - OptEx | $18.87 | +23.1K | 23.8K | +3,286% | +$435.9K |
| D | 2022-05-12 | 2022-05-10 | MRNA | Moderna | Nader Francois | Dir | S - Sale+OE | $136.10 | -3,196 | 20.6K | -13% | -$435.0K |
| D | 2022-05-02 | 2022-04-28 | MRNA | Moderna | Nader Francois | Dir | M - OptEx | $0.00 | +703 | 703 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations